Berdazimer Sodium | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Berdazimer Sodium
US Patents

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

Contact Supplier

Evonik

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

Berdazimer Sodium

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

31 Drugs in Development

31 Drugs in Development

FINISHED DOSAGE FORMULATIONS

1 FDF Dossiers, 1 FDA Orange Book

1 FDF Dossiers
1 FDA Orange Book

MARKET PLACE

1 APIs

1 APIs

PATENTS & EXCLUSIVITIES

22 US Patents, 1 US Exclusivities

22 US Patents
1 US Exclusivities

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

22 All

01 22LNHC

filter Patent Number Reset all filters

22 All

01 18282967

02 18956658

03 19289442

04 19526738

05 19737561

06 29855211

07 310258564

08 110265334

09 410322081

10 110376538

11 310736839

12 111040006

13 111285098

14 111723858

filter API Patent Reset all filters

22 All

01 2Y

02 20Blank

filter FDF Patent Reset all filters

22 All

01 9Y

02 13Blank

filter Expiration Date Reset all filters

22 All

01 22026-05-30

02 22030-08-20

03 12031-09-03

04 22032-07-03

05 22034-02-27

06 12034-02-28

07 32034-11-22

08 92035-07-10

Product Main Page

01

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 11723858

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217424

Patent Use Code : U-3788

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 11040006

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 217424

Patent Use Code : U-3789

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

03

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 10736839

Drug Substance Claim :

Drug Product Claim :

Application Number : 217424

Patent Use Code : U-3790

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

04

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 10736839

Drug Substance Claim :

Drug Product Claim :

Application Number : 217424

Patent Use Code : U-3791

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

05

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 10736839

Drug Substance Claim :

Drug Product Claim :

Application Number : 217424

Patent Use Code : U-3792

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 10322081

Drug Substance Claim :

Drug Product Claim :

Application Number : 217424

Patent Use Code : U-3793

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

07

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 10322081

Drug Substance Claim :

Drug Product Claim :

Application Number : 217424

Patent Use Code : U-3794

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

08

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 10322081

Drug Substance Claim :

Drug Product Claim :

Application Number : 217424

Patent Use Code : U-3795

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2035-07-10

BERDAZIMER SODIUM

US Patent Number : 10322081

Drug Substance Claim :

Drug Product Claim :

Application Number : 217424

Patent Use Code : U-3796

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2035-07-10

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

LNHC

BERDAZIMER SODIUM

ACS Fall 2025

Not Confirmed

LNHC

Country

ACS Fall 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-11-22

BERDAZIMER SODIUM

US Patent Number : 10258564

Drug Substance Claim :

Drug Product Claim :

Application Number : 217424

Patent Use Code : U-3797

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-11-22

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!